A phase I/II trial of enzalutamide plus the glucocorticoid receptor antagonist mifepristone for patients with metastatic castration-resistant prostate cancer (mCRPC). Background: Provocative evidence ...
Please provide your email address to receive an email when new articles are posted on . Exercise 3 days a week conferred more benefit than usual care for men with prostate cancer and erectile ...
Regular cardio and resistance training can improve blood flow, which may help remedy erectile dysfunction, a new study shows. Most men experience sexual issues, including erectile dysfunction, after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results